Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress

Nenad Jovanović, Sofija Jovanović, Aleksandar Jovanović, Andre Terzic

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Metabolic injury is a complex process affecting various tissues, with intracellular Ca2+ loading recognized as a common precipitating event leading to cell death. We have recently observed that cells overexpressing recombinant ATP-sensitive K+ (K(ATP)) channel subunits may acquire resistance against metabolic stress. To examine whether, under metabolic challenge, intracellular Ca2+ homeostasis can be maintained by an activator of channel proteins, we delivered Kir6.2 and SUR2A genes, which encode K(ATP) channel subunits, into a somatic cell line lacking native K(ATP) channels. Hypoxia-reoxygenation was simulated by application and removal of the mitochondrial poison 2,4 dinitrophenol. Under such metabolic stress, Ca2+ loading was induced by Ca2+ influx during hypoxia and release of Ca2+ from intracellular stores during reoxygenation. Delivery of Kir6.2/SUR2A genes, in conjunction with the K(ATP) channel activator pinacidil, prevented intracellular Ca2+ loading irrespective of whether the channel opener was applied throughout the duration of hypoxia-reoxygenation or transiently during the hypoxic or reoxygenation stage. In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K(ATP) channel, 5-hydroxydecanoate. The present study provides evidence that combined use of gene delivery and pharmacological targeting of recombinant proteins can handle intracellular Ca2+ homeostasis under hypoxia- reoxygenation irrespective of the stage of the metabolic insult.

Original languageEnglish (US)
Pages (from-to)923-929
Number of pages7
JournalFASEB Journal
Volume13
Issue number8
StatePublished - 1999

Fingerprint

Pinacidil
Physiological Stress
gene transfer
homeostasis
Homeostasis
Genes
Adenosine Triphosphate
calcium
hypoxia
2,4-Dinitrophenol
Poisons
2,4-dinitrophenol
Wounds and Injuries
Cell death
Recombinant Proteins
somatic cells
recombinant proteins
Cell Death
cell death
Cells

Keywords

  • Gene therapy
  • Ischemia
  • K(ATP) channels
  • Potassium channel opener

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress. / Jovanović, Nenad; Jovanović, Sofija; Jovanović, Aleksandar; Terzic, Andre.

In: FASEB Journal, Vol. 13, No. 8, 1999, p. 923-929.

Research output: Contribution to journalArticle

Jovanović, Nenad ; Jovanović, Sofija ; Jovanović, Aleksandar ; Terzic, Andre. / Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress. In: FASEB Journal. 1999 ; Vol. 13, No. 8. pp. 923-929.
@article{c4246089dc924cd0adaf3e701a409de8,
title = "Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress",
abstract = "Metabolic injury is a complex process affecting various tissues, with intracellular Ca2+ loading recognized as a common precipitating event leading to cell death. We have recently observed that cells overexpressing recombinant ATP-sensitive K+ (K(ATP)) channel subunits may acquire resistance against metabolic stress. To examine whether, under metabolic challenge, intracellular Ca2+ homeostasis can be maintained by an activator of channel proteins, we delivered Kir6.2 and SUR2A genes, which encode K(ATP) channel subunits, into a somatic cell line lacking native K(ATP) channels. Hypoxia-reoxygenation was simulated by application and removal of the mitochondrial poison 2,4 dinitrophenol. Under such metabolic stress, Ca2+ loading was induced by Ca2+ influx during hypoxia and release of Ca2+ from intracellular stores during reoxygenation. Delivery of Kir6.2/SUR2A genes, in conjunction with the K(ATP) channel activator pinacidil, prevented intracellular Ca2+ loading irrespective of whether the channel opener was applied throughout the duration of hypoxia-reoxygenation or transiently during the hypoxic or reoxygenation stage. In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K(ATP) channel, 5-hydroxydecanoate. The present study provides evidence that combined use of gene delivery and pharmacological targeting of recombinant proteins can handle intracellular Ca2+ homeostasis under hypoxia- reoxygenation irrespective of the stage of the metabolic insult.",
keywords = "Gene therapy, Ischemia, K(ATP) channels, Potassium channel opener",
author = "Nenad Jovanović and Sofija Jovanović and Aleksandar Jovanović and Andre Terzic",
year = "1999",
language = "English (US)",
volume = "13",
pages = "923--929",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

TY - JOUR

T1 - Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress

AU - Jovanović, Nenad

AU - Jovanović, Sofija

AU - Jovanović, Aleksandar

AU - Terzic, Andre

PY - 1999

Y1 - 1999

N2 - Metabolic injury is a complex process affecting various tissues, with intracellular Ca2+ loading recognized as a common precipitating event leading to cell death. We have recently observed that cells overexpressing recombinant ATP-sensitive K+ (K(ATP)) channel subunits may acquire resistance against metabolic stress. To examine whether, under metabolic challenge, intracellular Ca2+ homeostasis can be maintained by an activator of channel proteins, we delivered Kir6.2 and SUR2A genes, which encode K(ATP) channel subunits, into a somatic cell line lacking native K(ATP) channels. Hypoxia-reoxygenation was simulated by application and removal of the mitochondrial poison 2,4 dinitrophenol. Under such metabolic stress, Ca2+ loading was induced by Ca2+ influx during hypoxia and release of Ca2+ from intracellular stores during reoxygenation. Delivery of Kir6.2/SUR2A genes, in conjunction with the K(ATP) channel activator pinacidil, prevented intracellular Ca2+ loading irrespective of whether the channel opener was applied throughout the duration of hypoxia-reoxygenation or transiently during the hypoxic or reoxygenation stage. In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K(ATP) channel, 5-hydroxydecanoate. The present study provides evidence that combined use of gene delivery and pharmacological targeting of recombinant proteins can handle intracellular Ca2+ homeostasis under hypoxia- reoxygenation irrespective of the stage of the metabolic insult.

AB - Metabolic injury is a complex process affecting various tissues, with intracellular Ca2+ loading recognized as a common precipitating event leading to cell death. We have recently observed that cells overexpressing recombinant ATP-sensitive K+ (K(ATP)) channel subunits may acquire resistance against metabolic stress. To examine whether, under metabolic challenge, intracellular Ca2+ homeostasis can be maintained by an activator of channel proteins, we delivered Kir6.2 and SUR2A genes, which encode K(ATP) channel subunits, into a somatic cell line lacking native K(ATP) channels. Hypoxia-reoxygenation was simulated by application and removal of the mitochondrial poison 2,4 dinitrophenol. Under such metabolic stress, Ca2+ loading was induced by Ca2+ influx during hypoxia and release of Ca2+ from intracellular stores during reoxygenation. Delivery of Kir6.2/SUR2A genes, in conjunction with the K(ATP) channel activator pinacidil, prevented intracellular Ca2+ loading irrespective of whether the channel opener was applied throughout the duration of hypoxia-reoxygenation or transiently during the hypoxic or reoxygenation stage. In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K(ATP) channel, 5-hydroxydecanoate. The present study provides evidence that combined use of gene delivery and pharmacological targeting of recombinant proteins can handle intracellular Ca2+ homeostasis under hypoxia- reoxygenation irrespective of the stage of the metabolic insult.

KW - Gene therapy

KW - Ischemia

KW - K(ATP) channels

KW - Potassium channel opener

UR - http://www.scopus.com/inward/record.url?scp=0032948514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032948514&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 923

EP - 929

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -